For information regarding remdesivir, please click here.

ACCESS OUR LIBRARY OF AVAILABLE
REMDESIVIR RESOURCES

Remdesivir (GS-5734™) is an investigational, broad-spectrum antiviral that is currently in development for a range of infectious conditions. Remdesivir is currently being evaluated in ongoing clinical studies of patients with COVID-19. The efficacy and safety of remdesivir for the treatment of COVID-19 have not been determined, and it is not approved for any use. Remdesivir must be administered intravenously.

In response to a public health emergency, the U.S. FDA has issued an Emergency Use Authorization (EUA) for the unapproved product, remdesivir, for the treatment of COVID-19. The distribution of remdesivir has been authorized only for the treatment of hospitalized patients with severe COVID-19. This use is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use, unless the authorization is terminated or revoked sooner. For information about the authorized use of remdesivir and mandatory requirements of the Emergency Use Authorization in the U.S., please review the Fact Sheet for Healthcare Providers and FDA Letter of Authorization available below.

This information is updated regularly, please check back for updates.

* required field
  • Search tips:

    • Use more terms to refine and narrow the search results
      • Results will include resources with any one of those terms by themselves or together
    • Use “and” between terms to find a resource containing multiple keywords
      • Results will only include resources with all of the searched terms within
    • Use quotations marks around your terms to search for a specific phrase in a resource
      • Results will only include resources containing that exact phrase and exclude other phrasings of those terms

Chat

Our chat service is coming soon. Please utilize other features such as search, call, or inquire to obtain the information you’re requesting.

Search

* required field

Medical Inquiry

To get more information about our products, please provide a few details and our team will contact you.

* required field

Thank you, your inquiry has been submitted.

If you are a patient, please discuss this question and any others you may have about your medical condition, treatment, or medicines with your doctor.

Meeting Request

The ability to request a meeting with a Gilead Medical Scientist is coming soon. Please utilize other features such as search, call, or inquire to obtain the information you’re requesting.

Thank you, your request has been submitted.

By clicking “I’m a US healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the US. This site is an educational resource for US healthcare professionals and may include products or uses that have not been approved by the US Food and Drug Administration.

OK

You are leaving this website

By clicking this link, you will be leaving the Gilead Medical Information website and will be redirected to another webpage.

You are leaving this website

By clicking this link, you will be leaving the Gilead Medical Information website and will be redirected to the Gilead Corporate website.

Once redirected, click on "Global Operations" in the top right corner of the homepage and choose the country you are seeking Gilead product information in.

Welcome to
Gilead Medical Information

This site is an online medical resource that provides access to the most current, accurate, and evidence-based information about Gilead products. The information provided is in response to unsolicited requests and is not intended to be promotional or provide medical advice.

Choose an option that describes you:

By clicking “I’m a USA healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the USA. The site you are entering is an educational resource for USA healthcare professionals and may include products or uses that have not been approved by the USA Food and Drug Administration.